James Michael Kirshenbaum, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pericardiocentesis | 1 | 2017 | 74 | 0.590 |
Why?
|
| Cardiac Tamponade | 2 | 2017 | 173 | 0.560 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2014 | 173 | 0.430 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2010 | 1262 | 0.370 |
Why?
|
| Thrombosis | 3 | 2014 | 2966 | 0.350 |
Why?
|
| Tricuspid Valve | 3 | 2019 | 400 | 0.350 |
Why?
|
| Myocarditis | 2 | 2014 | 770 | 0.330 |
Why?
|
| Thrombolytic Therapy | 6 | 2010 | 2161 | 0.300 |
Why?
|
| Dyspnea | 3 | 2019 | 1298 | 0.280 |
Why?
|
| Foramen Ovale, Patent | 2 | 2019 | 223 | 0.270 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2019 | 346 | 0.260 |
Why?
|
| Propanolamines | 5 | 1989 | 167 | 0.260 |
Why?
|
| Heart | 4 | 2014 | 4462 | 0.240 |
Why?
|
| Diazepam | 2 | 2020 | 205 | 0.220 |
Why?
|
| Fibrinolytic Agents | 2 | 2010 | 2156 | 0.190 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1440 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 1515 | 0.180 |
Why?
|
| Hydroxychloroquine | 2 | 2020 | 408 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6347 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 6 | 1992 | 1239 | 0.160 |
Why?
|
| Angioplasty, Balloon, Coronary | 6 | 2010 | 1873 | 0.150 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2018 | 133 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2010 | 2789 | 0.140 |
Why?
|
| Medication Reconciliation | 1 | 2018 | 151 | 0.140 |
Why?
|
| Myocardial Infarction | 13 | 2010 | 11690 | 0.140 |
Why?
|
| Pharmacists | 1 | 2018 | 240 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 8829 | 0.130 |
Why?
|
| Professional Role | 1 | 2018 | 306 | 0.130 |
Why?
|
| Diagnosis, Differential | 7 | 2019 | 12958 | 0.120 |
Why?
|
| Heart Valve Prosthesis | 2 | 2015 | 1486 | 0.120 |
Why?
|
| Plasmapheresis | 1 | 2014 | 212 | 0.120 |
Why?
|
| Cough | 1 | 2017 | 555 | 0.110 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 1991 | 337 | 0.110 |
Why?
|
| Coronary Disease | 10 | 2000 | 6078 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13019 | 0.110 |
Why?
|
| Infusions, Intravenous | 5 | 2010 | 2271 | 0.110 |
Why?
|
| Echocardiography | 5 | 2019 | 5097 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1849 | 0.100 |
Why?
|
| Suicide, Attempted | 1 | 2020 | 1218 | 0.100 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 684 | 0.100 |
Why?
|
| Endocarditis | 1 | 2015 | 348 | 0.100 |
Why?
|
| Prosthesis-Related Infections | 1 | 2015 | 538 | 0.090 |
Why?
|
| Coronary Circulation | 2 | 2014 | 1572 | 0.090 |
Why?
|
| Myocardium | 2 | 2014 | 4775 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 2906 | 0.080 |
Why?
|
| Exercise Test | 3 | 2014 | 2075 | 0.080 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 194 | 0.080 |
Why?
|
| Anticoagulants | 3 | 2014 | 4595 | 0.080 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2010 | 169 | 0.080 |
Why?
|
| Electrocardiography | 6 | 2014 | 6440 | 0.080 |
Why?
|
| Meningitis, Meningococcal | 1 | 1987 | 43 | 0.070 |
Why?
|
| Heart Neoplasms | 1 | 2010 | 374 | 0.070 |
Why?
|
| Catheters, Indwelling | 2 | 2019 | 425 | 0.070 |
Why?
|
| Thiophenes | 1 | 2010 | 590 | 0.070 |
Why?
|
| Pericarditis | 1 | 1987 | 128 | 0.070 |
Why?
|
| Hemodynamics | 6 | 1989 | 4197 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2010 | 899 | 0.060 |
Why?
|
| Lung Diseases, Fungal | 1 | 1985 | 122 | 0.060 |
Why?
|
| Pulmonary Embolism | 3 | 2019 | 2370 | 0.060 |
Why?
|
| Angioplasty, Balloon | 3 | 2001 | 653 | 0.060 |
Why?
|
| Catheterization | 1 | 2010 | 1468 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2014 | 1194 | 0.060 |
Why?
|
| Organotechnetium Compounds | 3 | 1991 | 137 | 0.060 |
Why?
|
| Heart Atria | 1 | 2010 | 1348 | 0.060 |
Why?
|
| Aspergillosis | 1 | 1985 | 235 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 3067 | 0.060 |
Why?
|
| Cardiology | 1 | 2014 | 1658 | 0.050 |
Why?
|
| Platelet Aggregation | 2 | 2001 | 800 | 0.050 |
Why?
|
| Thromboembolism | 2 | 2019 | 983 | 0.050 |
Why?
|
| Biopsy | 1 | 2014 | 6756 | 0.050 |
Why?
|
| Coronary Thrombosis | 3 | 1991 | 494 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
| Prognosis | 4 | 2017 | 29010 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6259 | 0.050 |
Why?
|
| Humans | 45 | 2020 | 742088 | 0.050 |
Why?
|
| Angina Pectoris, Variant | 1 | 2000 | 55 | 0.050 |
Why?
|
| Piperazines | 1 | 2010 | 2488 | 0.050 |
Why?
|
| Middle Aged | 26 | 2017 | 213127 | 0.040 |
Why?
|
| Male | 32 | 2020 | 349538 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 62966 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3507 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2010 | 3461 | 0.040 |
Why?
|
| Nitriles | 3 | 1991 | 952 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2019 | 1527 | 0.040 |
Why?
|
| Vasodilator Agents | 3 | 2003 | 976 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2055 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2000 | 548 | 0.040 |
Why?
|
| Angina, Unstable | 2 | 1999 | 926 | 0.040 |
Why?
|
| Pulmonary Artery | 1 | 1985 | 1911 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2010 | 5978 | 0.040 |
Why?
|
| Tyrosine | 1 | 2001 | 1460 | 0.040 |
Why?
|
| Adult | 16 | 2020 | 213712 | 0.030 |
Why?
|
| Potassium | 1 | 2020 | 1336 | 0.030 |
Why?
|
| Female | 29 | 2019 | 379592 | 0.030 |
Why?
|
| Coronary Angiography | 7 | 2003 | 4567 | 0.030 |
Why?
|
| Anistreplase | 1 | 1994 | 12 | 0.030 |
Why?
|
| Technetium | 2 | 1986 | 334 | 0.030 |
Why?
|
| Heart Transplantation | 4 | 1989 | 3119 | 0.030 |
Why?
|
| Coronary Artery Disease | 2 | 2014 | 6454 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 1141 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 1989 | 4147 | 0.030 |
Why?
|
| Myocardial Reperfusion | 2 | 1991 | 351 | 0.030 |
Why?
|
| Vascular Patency | 2 | 1994 | 885 | 0.030 |
Why?
|
| Sepsis | 1 | 1987 | 2589 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15108 | 0.030 |
Why?
|
| Scoliosis | 1 | 2019 | 719 | 0.030 |
Why?
|
| Cause of Death | 1 | 2003 | 3571 | 0.030 |
Why?
|
| Hypercholesterolemia | 2 | 1989 | 1149 | 0.030 |
Why?
|
| Organometallic Compounds | 2 | 1986 | 665 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1991 | 6608 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8328 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1991 | 425 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1991 | 1420 | 0.020 |
Why?
|
| Lovastatin | 1 | 1989 | 120 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 1989 | 176 | 0.020 |
Why?
|
| Plasminogen Activators | 1 | 1989 | 209 | 0.020 |
Why?
|
| Stents | 1 | 2000 | 3276 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1974 | 802 | 0.020 |
Why?
|
| Streptokinase | 1 | 1988 | 188 | 0.020 |
Why?
|
| Fibrinogen | 1 | 1991 | 894 | 0.020 |
Why?
|
| Aged | 15 | 2018 | 162944 | 0.020 |
Why?
|
| Fat Necrosis | 1 | 1988 | 58 | 0.020 |
Why?
|
| Nitrates | 1 | 1989 | 265 | 0.020 |
Why?
|
| Radiography | 1 | 2019 | 7010 | 0.020 |
Why?
|
| Tachycardia | 1 | 2010 | 620 | 0.020 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2010 | 361 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1988 | 264 | 0.020 |
Why?
|
| Nitroglycerin | 2 | 1988 | 325 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 2 | 1989 | 1527 | 0.020 |
Why?
|
| Heart Rate | 3 | 1988 | 4091 | 0.020 |
Why?
|
| Patient Selection | 1 | 1999 | 4214 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 2013 | 0.020 |
Why?
|
| Neisseria meningitidis | 1 | 1987 | 109 | 0.020 |
Why?
|
| Standard of Care | 1 | 2010 | 562 | 0.020 |
Why?
|
| Serotyping | 1 | 1987 | 338 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1991 | 1107 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1991 | 1961 | 0.020 |
Why?
|
| Troponin | 1 | 2010 | 524 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1989 | 689 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1988 | 853 | 0.020 |
Why?
|
| Acetylcholine | 1 | 1988 | 621 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2010 | 681 | 0.020 |
Why?
|
| Breast | 1 | 1974 | 1958 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8297 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 1990 | 1203 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2010 | 921 | 0.020 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1984 | 59 | 0.020 |
Why?
|
| Angina Pectoris | 2 | 1986 | 977 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1459 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1995 | 2145 | 0.020 |
Why?
|
| Aspergillus fumigatus | 1 | 1985 | 150 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2018 | 3111 | 0.010 |
Why?
|
| Abscess | 1 | 1988 | 607 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1402 | 0.010 |
Why?
|
| Time Factors | 7 | 1991 | 40054 | 0.010 |
Why?
|
| Necrosis | 1 | 1988 | 1643 | 0.010 |
Why?
|
| Alcoholic Intoxication | 1 | 1984 | 188 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2014 | 53187 | 0.010 |
Why?
|
| Nitroprusside | 1 | 2003 | 275 | 0.010 |
Why?
|
| Verapamil | 1 | 2003 | 244 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 57683 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1984 | 1144 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
| Pancreatitis | 1 | 1988 | 1090 | 0.010 |
Why?
|
| Physiology | 1 | 2001 | 113 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1985 | 3913 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 39004 | 0.010 |
Why?
|
| Platelet Function Tests | 1 | 2001 | 270 | 0.010 |
Why?
|
| Thallium Radioisotopes | 1 | 1999 | 139 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1988 | 1065 | 0.010 |
Why?
|
| Clinical Trials as Topic | 3 | 2010 | 7901 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2001 | 482 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2001 | 641 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1981 | 647 | 0.010 |
Why?
|
| Risk Factors | 3 | 2018 | 72145 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1988 | 3164 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2003 | 9846 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1988 | 3099 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1988 | 4554 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1986 | 2267 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19862 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1988 | 8541 | 0.010 |
Why?
|
| Uric Acid | 1 | 1981 | 760 | 0.010 |
Why?
|
| Acute Disease | 2 | 2000 | 7141 | 0.010 |
Why?
|
| Infusions, Parenteral | 2 | 1985 | 415 | 0.010 |
Why?
|
| Light | 1 | 2001 | 1374 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2010 | 23320 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15056 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1999 | 2615 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2001 | 1175 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69693 | 0.010 |
Why?
|
| Bilirubin | 1 | 1974 | 424 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1991 | 176 | 0.010 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1974 | 600 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2001 | 2506 | 0.010 |
Why?
|
| Cholesterol, LDL | 2 | 1989 | 2354 | 0.010 |
Why?
|
| Cyclosporins | 1 | 1988 | 220 | 0.010 |
Why?
|
| Peptides | 1 | 2001 | 4392 | 0.010 |
Why?
|
| Heparin | 1 | 1994 | 1636 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1988 | 528 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1989 | 15244 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1974 | 20774 | 0.000 |
Why?
|
| Double-Blind Method | 2 | 1994 | 12017 | 0.000 |
Why?
|
| Mastectomy | 1 | 1974 | 1789 | 0.000 |
Why?
|
| Heart Ventricles | 2 | 1989 | 3801 | 0.000 |
Why?
|
| Iron | 1 | 1974 | 1773 | 0.000 |
Why?
|
| Scleroderma, Systemic | 1 | 1989 | 313 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2003 | 21719 | 0.000 |
Why?
|
| Cohort Studies | 2 | 1999 | 40450 | 0.000 |
Why?
|
| Coronary Care Units | 1 | 1986 | 214 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 6483 | 0.000 |
Why?
|
| Propranolol | 1 | 1986 | 502 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1989 | 1661 | 0.000 |
Why?
|
| Prednisone | 1 | 1988 | 1567 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 9274 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 56350 | 0.000 |
Why?
|
| Streptococcal Infections | 1 | 1988 | 637 | 0.000 |
Why?
|
| Heart Failure | 1 | 1987 | 10856 | 0.000 |
Why?
|
| Aspirin | 1 | 1994 | 3278 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1999 | 9941 | 0.000 |
Why?
|
| Cholesterol, HDL | 1 | 1988 | 1813 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1984 | 695 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1986 | 2027 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1995 | 12242 | 0.000 |
Why?
|
| Random Allocation | 1 | 1986 | 2425 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1985 | 793 | 0.000 |
Why?
|
| Triglycerides | 1 | 1988 | 2450 | 0.000 |
Why?
|
| Animals | 3 | 1989 | 168561 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1981 | 379 | 0.000 |
Why?
|
| Dogs | 1 | 1985 | 3910 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1984 | 2335 | 0.000 |
Why?
|
| Cholesterol | 1 | 1989 | 2895 | 0.000 |
Why?
|
| Angiography | 1 | 1986 | 1636 | 0.000 |
Why?
|
| Logistic Models | 1 | 1995 | 13403 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 14720 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1988 | 4771 | 0.000 |
Why?
|
| Syndrome | 1 | 1985 | 3248 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1985 | 1869 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 2003 | 77098 | 0.000 |
Why?
|
| Hybridization, Genetic | 1 | 1974 | 109 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1986 | 10943 | 0.000 |
Why?
|
| Adolescent | 2 | 1988 | 85649 | 0.000 |
Why?
|
| Species Specificity | 1 | 1974 | 2479 | 0.000 |
Why?
|
| Rabbits | 1 | 1974 | 4886 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1985 | 18006 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1974 | 2623 | 0.000 |
Why?
|
| Protein Binding | 1 | 1974 | 9387 | 0.000 |
Why?
|
| Sex Factors | 1 | 1974 | 10392 | 0.000 |
Why?
|